Drug details
Ruzurgi (amifampridine tablets)
type of Potassium Channel Blockers
Ruzurgi (amifampridine) is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- severe dizziness, and
- seizure
The following drugs are related to Ruzurgi, either as a replacement or used together:
- Firdapse (amifampridine tablets)